药物对比
Semaglutide vs Sotagliflozin
比较Semaglutide（Ozempic）与Sotagliflozin（Inpefa）：GLP-1受体激动剂与双重SGLT抑制剂治疗2型糖尿病、减重和心力衰竭。看看哪种可能更好。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered for type 2 diabetes patients who also have heart failure or high cardiovascular risk, weighing a GLP-1 agonist against a dual SGLT inhibitor.
结论
Semaglutide is generally stronger for weight reduction and A1C lowering, while Sotagliflozin offers distinct cardiorenal protection, so the better option is highly patient-specific.
全部药物对比